Proneuron Biotechnologies Company Profile

19:48 EDT 24th March 2018 | BioPortfolio

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS, Huntington’s and Alzheimer’s diseases. The brain, spinal cord and optic nerves comprise the central nervous system (CNS) one of the most complex and enigmatic systems in nature. The CNS is responsible for consciousness, memory, intelligence, the five senses, and controlled movement. However, these functions may be disrupted by brain damage, spinal injury or disease, causing severe disability, such as paralysis, blindness, or loss of mental capabilities. The disability is often permanent because the CNS has a very limited capacity for healing and self repair.While there is no paralysis cure yet available to treat spinal cord injury, nor any cure for CNS trauma in general, scientists at the Weizmann Institute of Science and Proneuron have demonstrated that CNS recovery may be enhanced by applying the body’s own repair system, the immune system, which is actively involved in wound-healing in other parts of the body. In the quest for a paralysis cure, Proneuron is pursuing an aggressive research and development program based on proprietary immune-modulating technology. Proneuron's lead product is ProCord, an experimental cell therapy that is being developed to treat acute spinal cord injury. Besides spinal cord injuries, additional products are being developed for other debilitating neurological indications


Weizmann Science Park, Building 14,P.O.B. 277


Phone: 972-8-9409550
Fax: 972-8-9409560

News Articles [83 Associated News Articles listed on BioPortfolio]

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

Elanix Biotechnologies: Erfolgreiche Studie

Transwell Biotech, ein Partner von Elanix Biotechnologies, schließt eine Phase-I Studie zur Wundbehandlung bei Hauttransplantaten ab. Das Produkt von Transwell kombiniert ein Hydrogel mit kryokonse.....

Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Manual

$59.99End Date: Thursday Dec-7-2017 11:05:38 PSTBuy It Now for only: $59.99Buy It Now | Add to watch list Biotech365 : Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Ma...

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

Elanix Biotechnologies: Neues zur Kapitalerhöhung

Bei Elanix Biotechnologies steht eine Kapitalerhöhung an. Ausgegeben werden fast 1,7 Millionen neue Aktien. Aktionäre können die Papiere im Verhältnis 4:1 zeichnen. Für vier alte Aktien wird es e...

Azelis and Tagra Biotechnologies Extend Partnership

Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France and Benelux, w...

ProMab Biotechnologies Acquires One World Lab

ProMab Biotechnologies, a manufacturer of monoclonal antibodies and immunotherapy related products and services, has acquired One World Lab, a marketplace exclusive to manufacturers. SAN DIEGO (PRWEB)...

Drugs and Medications [0 Results]


PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats.

Global Catastrophic Biological Risks (GCBRs) refer to biological events-natural, deliberate, and accidental-of a global and lasting impact. This challenges the life scientists to raise their game on t...

Technologies for the bioconversion of methane into more valuable products.

Methane, with a global warming potential twenty five times higher than that of CO2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high ...

Light-trigerred Cellular Epigenetic Molecule Release to Reverse Tumor Multi-drug Resistance.

Owing to the high spatial and temporal resolution of light, light related biotechnologies, for example, optogenetics, has wide ranging applications in neuroscience to control a subject's behavior. App...

Clinical Trials [0 Results]


Companies [103 Associated Companies listed on BioPortfolio]

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...

Proneuron Biotechnologies

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Proneuron Biotechnologies" on BioPortfolio

We have published hundreds of Proneuron Biotechnologies news stories on BioPortfolio along with dozens of Proneuron Biotechnologies Clinical Trials and PubMed Articles about Proneuron Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proneuron Biotechnologies Companies in our database. You can also find out about relevant Proneuron Biotechnologies Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Corporate Database Quicklinks

Searches Linking to this Company Record